2015
DOI: 10.1096/fj.15-273813
|View full text |Cite
|
Sign up to set email alerts
|

Exploiting chimeric human antibodies to characterize a protective epitope ofNeisseriaadhesin A, one of the Bexsero vaccine components

Abstract: Neisseria adhesin A (NadA) is one of the antigens of Bexsero, the recently licensed multicomponent vaccine against serogroup B Neisseria meningitidis (MenB). NadA belongs to the class of oligomeric coiled-coil adhesins and is able to mediate adhesion and invasion of human epithelial cells. As a vaccine antigen, NadA has been shown to induce high levels of bactericidal antibodies; however, the domains important for protective response are still unknown. In order to further investigate its immunogenic properties… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 36 publications
0
15
0
Order By: Relevance
“…The NadA5 crystal structure included only residues 24 to 137, and no structural information was available for the C-terminal region, including the predicted coiled coil and the highly conserved membrane anchor domain. The NadA5 crystal structure was used as a template to generate a homology model of NadA3, which has been used to aid interpretation of epitope mapping studies ( 30 32 ). Recently, a panel of 18 human monoclonal antibodies (humAbs) against NadA were isolated from human subjects vaccinated with 4CMenB ( 32 ).…”
Section: Introductionmentioning
confidence: 99%
“…The NadA5 crystal structure included only residues 24 to 137, and no structural information was available for the C-terminal region, including the predicted coiled coil and the highly conserved membrane anchor domain. The NadA5 crystal structure was used as a template to generate a homology model of NadA3, which has been used to aid interpretation of epitope mapping studies ( 30 32 ). Recently, a panel of 18 human monoclonal antibodies (humAbs) against NadA were isolated from human subjects vaccinated with 4CMenB ( 32 ).…”
Section: Introductionmentioning
confidence: 99%
“…The use of improved HDX-MS workflows enables the structural analysis of larger protein systems such as antigen-antibody complexes (> 180 kDa) or integral membrane proteins, in a more routine way (Bertoldi et al , 2016; Chung et al , 2011; Faleri et al , 2014; Malito et al , 2014; Malito et al , 2013). The characterization of such systems results in very complex HDX-MS datasets, for which specific non-commercial analytical software (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…We used HDX coupled to MS to allow the mapping of conformational epitopes ( 21 27 ). The approach was also compared with the most sophisticated and available approaches such as protein chip ( 26 , 27 ), phage display ( 21 , 26 , 27 ), X-ray ( 21 ), and cryo-EM ( 24 , 25 ). Modern HDX–MS is more straightforward, rapid, and routine than in the past.…”
Section: Novel Technologies For Epitope Mapping For Vaccine Design Amentioning
confidence: 99%
“…The approach has sufficient resolution to recognize fHbp overlapping epitopes with different functional properties ( 22 ). It was also successfully applied to map epitopes from NadA ( 23 , 26 ) and NHBA ( 27 ), the two other protective epitopes of the vaccine against group B meningococcus, Bexsero. Hybrid approaches making use of HDX–MS and electron microscopy also evidenced the power of HDX–MS to map viral antigen epitopes of CMV gH–gL complex.…”
Section: Novel Technologies For Epitope Mapping For Vaccine Design Amentioning
confidence: 99%